Filter posts

Announcing the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey

Click here for the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey. Your investment plans and …

Chairman Upton and Rep. DeGette Op-Ed: Can We Find Cures for 7,000 Diseases?

In a CNN.com op-ed, Energy & Commerce Committee Chairman Fred Upton (R-MI) and Representative Diana …

J.P. Morgan Turns All Eyes toward Biotech

BioWorld’s Peter Winter reports that the mood is upbeat at today’s kickoff of the 33rd …

Exclusive FDA Survey Webinar

BIO is conducting an exciting new survey designed to measure FDA/Sponsor Interactions During Drug Development.  …

Don’t Go At It Alone- BIO BizLink and the Evolving R&D Marketplace

With companies in the biotechnology industry more frequently outsourcing R&D pipelines, selecting the right contract …

Boston Globe: Helping veterans find a career path in life sciences

Mike Minogue, chairman and chief executive of Abiomed, a medical device company in Boston that makes …

SPARKs Fly When Stanford Profs Talk BD with Industry Leads

5:30 PM, October 8th, 2014. Li Ka Shing Learning & Knowledge Center, Stanford University. Stanford’s …

BIO Investor Forum Closing Plenary: How Fragile is the Biotech Rally After Five Positive Years?

Last week’s 13th Annual BIO Investor Forum closed on Wednesday with a plenary session asking, …

Answering the Call for Cures in Michigan

This week, the Kalamazoo Gazette published an op-ed on how we can accelerate the discovery, …

Biotech CEOs Talk JOBS Act and IPO Experiences at 2014 BIO Investor Forum

The JOBS Act has contributed to a dramatic acceleration in new biotech IPOs since its …